In the US, incidence rates of kidney cancer more than doubled from 2.5 per 100,000 in 2000 to 5.3 per 100,000 in 2023.
No event time was recorded for this claim — the text gave nothing to anchor it to, and a guessed date would be worse than none.
Standing
lens: Evidence-weighted Structural
No belief has been computed for this claim under Evidence-weighted yet.
What bears on it
Nothing supports or challenges this claim yet — untested, which is not the same as refuted.
Voices
- theguardian.com independent
Voices are counted, never weighed. How many people say a thing is structure worth seeing; it is not, by itself, a reason to believe it.
What the documents actually said
The verbatim text each extraction read before resolving it into this canonical claim. Quoted, never republished.
- In the US, incidence rates of kidney cancer more than doubled from 2.5 per 100,000 in 2000 to 5.3 per 100,000 in 2023.
In the US, analysis of official data since 2000 found that among patients under 50, incidence rates of kidney cancer more than doubled from 2.5 in 100,000 people in 2000 to 5.3 in 2023
Sources
Who and what it involves
Origin: extracted from Cancer rates rising more quickly among younger people, international research finds · 2026-10-10 19:59